Please assess the completion status of the following clinical trial:

Trial Title: Assessing Brain Changes Throughout the ABI Wellness Program

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Enrolled in but not initiated the ABI Wellness program~2. Male or female, 19-65 years old inclusively~3. Normal hearing capabilities~4. Able to understand the informed consent form, study procedures and willing to participate in study~5. Able to keep eyes still for 6 minutes~Exclusion Criteria:~1. Clinically documented hearing issues (e.g. in-ear hearing problems, punctured ear drum, etc.)~2. Score of 7 or lower on the Mini Mental State Exam (MMSE) - Orientation subscale~3. Implanted pacemaker~4. Metal or plastic implants in skull~5. In-ear hearing aid or cochlear implant, hearing device~6. Recent (within last 6 months) acquired brain injury~7. History of other neurological disorder (e.g. brain cancer, dementia, multiple sclerosis, stroke, etc.)~8. Exposed to investigational drug or device 30 days prior to start in this study, or concurrent use of investigational drug or device while enrolled in this study~9. Not fluent in English language~10. Unable to provide informed consent~11. Previous participation in studies using the NeuroCatch Platform™~12. If female and of child-bearing potential: pregnant, suspected or planning to become pregnant or breast-feeding~13. History of seizures~14. Allergy to rubbing alcohol or EEG gel

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Full-time Cognitive Rehabilitation Program (Type: EXPERIMENTAL): Participants in full-time program will be asked to complete 4 experimental sessions with the NeuroCatch Platform™ over the course of 3 months (i.e. one session/ month).
- Part-time Cognitive Rehabilitation Program (Type: EXPERIMENTAL): Participants in the part-time program will be asked to complete 3 experimental sessions with the NeuroCatch Platform™ over 3 months (i.e. one session/1.5 months).

Based on this trial design, predict the completion outcome and termination type (if applicable).